InvestorsHub Logo
Followers 1171
Posts 172771
Boards Moderated 4
Alias Born 12/20/2003

Re: None

Tuesday, 05/17/2022 8:03:22 AM

Tuesday, May 17, 2022 8:03:22 AM

Post# of 56
PALO ALTO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of the management team will participate in the following upcoming investor conferences:

Citi Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Panel, Virtual: Wednesday, May 18th at 2:30 pm ET
H. C. Wainwright Global Investment Conference, Virtual: Tuesday, May 24th at 7:00 am ET
UBS Global Healthcare Conference, New York, NY: Tuesday, May 24th at 11:30 am ET
J. P. Morgan West Coast Investor Day, San Francisco, CA: Tuesday, May 24th at 12:00 pm ET
To access more details on BridgeBio's presentations, please visit the "Events & Presentations" page within the Investors section of the BridgeBio website at http://investor.bridgebio.com.

History.htm

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BBIO News